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Postoperatively, the patients were treated with nonadherent paraffin-
impregnated gauze over the skin graft, and the leg was bandaged with
orthopedic wool and covered with a crepe bandage. Bed rest was maintained
for 5 days with leg elevation. Patients were discharged with a compression
bandage of nonadherent dressing, covered by orthopedic wool and then a
compressive wrap.
Operations were performed on 100 chronic leg ulcers in 62 patients. Of
these, 72 ulcers were venous, 8 were rheumatoid, 6 were ischemic, and 4
were lymphedematous; 3 were of mixed arterial and venous etiology, and 1
was associated with diabetes. All patients with ischemic ulcers had a revas-
cularization procedure before skin grafting.
The median ulcer size was 36 cm2 (range, 1.5 to 192 cm2).
At hospital discharge, 59 patients had healed ulcers and three had
unhealed ulcers. By 2 months, 28 of the ulcers (28%) had recurred. During
follow-up, a further 17 ulcers recurred. At 5 years, about 55% of the ulcers
remained healed. Ulcer recurrence did not differ with respect to whether the
ulcer was venous in origin or of another etiology (P .980). Occurrence was
also not affected by whether the ulcer was large (10 cm2) or small (P 
.686).
Comment: Tangential excision and skin grafting for chronic lower
extremity ulcers provides reasonable short-term results for most patients and
long-term ulcer healing for about half. The downside, of course, is that an
outpatient disorder is transferred into an inpatient problem. The median
postoperative stay in the patients in this series was 20 days (range, 12 to 40
days).
Influence of sex on expansion rate of abdominal aortic aneurysms
Mofidi R, Goldie VJ, Kelman J, Dawson ARW, et al. Br J Surg 2007;94:
310-4.
Conclusion: Abdominal aortic aneurysms (AAA) grow at a signifi-
cantly higher rate in women than men.
Summary: Longitudinal studies have indicated that aneurysms that
rupture have higher expansion rates than nonrupture aneurysms (J Vasc Surg
2003;37:280-4 and N Engl J Med 2002;346:1437-44). Larger aneurysms
grow at a higher rate than smaller aneurysms, and a recent screening
program suggested female sex is also a risk factor for more rapid growth of an
AAA (Eur J Vasc Endo Surg 2005;29:145-9). In this study, the authors
assess the effect of sex on growth rate of AAA. The authors studied patients
identified between January 1985 and August 2005. Some had AAA but were
not considered for early repair. These patients were followed up with serial
abdominal ultrasound examinations with measurements of maximum trans-
verse and anteroposterior dimensions.
A total of 1255 patients (824 men and 431 women) were followed up
for a median of 30 months (range, 6 to 185 months), with a median of six
examinations per patient (range, 2 to 37). The median initial diameter was
41 mm (range, 25 to 83 mm). Median growth rate was 2.79 mm/y (range,
–4.80 to 37.02 mm/y). Growth rate of AAAs in women was greater than
that in men: 3.67 mm/y (range. –1.2 to 37.02 mm/y) in women vs a
median growth rate in men of 2.03 mm/y (range -4.80 to 21.00 mm/y; P
 .01). By weighted linear regression analysis, the initial anteroposterior
AAA diameter (P  .001) and female sex (P  .006) were predictors of
increased AAA growth rate.
Conclusion: This is another bit of evidence suggesting that AAA
disease may be more virulent in women than men. Previous studies have
suggested rupture at smaller diameters in women than men, and now it
appears that female sex may be an independent risk factor for increased
expansion rate of an AAA. This type of emerging information has significant
implications for the timing of AAA repair in women and frequency of
nonoperative follow-up.
Optimal medical therapy with or without PCI for stable coronary
disease
BodenWE,O’Rourke RA, Teo KK, et al; for the COURAGETrial Research
Group. N Engl J Med 2007;356;1503-16.
Conclusion: Added to an initial medical management strategy in
patients with stable coronary artery disease, percutaneous coronary interven-
tion (PCI) does not reduce risk of death, myocardial infarction, or other
major cardiovascular events.
Summary: Approximately 85% of PCIs are performed electively in
patients with stable coronary disease (Am J Cardiology 2006; 98:1334-9).
PCI reduces death and myocardial infarction in patients with acute coronary
syndromes, but similar benefit has not been demonstrated in patients with
stable coronary disease, despite the high prevalence of PCI performed in
patients with stable coronary disease.
This article investigated whether an initial management strategy of PCI
added to optimal medical therapy (intensive pharmacologic therapy and
lifestyle intervention) reduced cardiovascular events compared with optimal
medical therapy alone. This was a randomized trial of 2287 patients with
objective evidence of coronary artery disease and myocardial ischemia. The
study was conducted in 50 centers in the United States and Canada between
1999 and 2004. There were 1149 patients randomized to undergo optimal
medical therapy in conjunction with PCI, and 1138 patients were random-
ized to receive optimal medical therapy alone. The primary outcome was
death from any cause and nonfatal myocardial infarction.
The median follow-up was 4.6 years (range, 2.5 to 7.0 years). The PCI
group experienced 211 primary events, and 202 events occurred in the
medical therapy group. In 4.6 years, cumulative events were 18.5% in the
medical therapy group and 19.0% in the PCI group (hazard ratio [HR] for
the PCI group, l.05; 95% confidence interval [CI], 0.87 to 1.27; P  .62).
The medical therapy group and the PCI group did not differ with respect to
the composite end point of death, myocardial infarction, and stroke (20.0%
vs 19.5%; HR, 1.05; 95% CI, 0.87 to 1.27; P  .62). Also, no differences
were found for hospitalization for acute coronary syndrome (12.4% vs
11.8%; HR, 1.07; 95% CI, 0.84 to 1.37; P  .56) or myocardial infarction
(13.2% vs 12.3%; HR, 1.13; 95% CI, 0.89 to 1.43; P  .33). At 4.6 years,
21.1% of the patients in the PCI group had additional revascularizations
compared with 32.6% in the medical therapy group (HR, 0.6; 95% CI, 0.51
to 0.71; P .001). Angina was reduced in in both groups during follow-up,
generally in favor of the PCI group. At 5 years, however, 74% of the patients
in the PCI group and 72% in the medical therapy group were free of angina
(P  .35).
Comment: PCI, as an additional strategy to optimal medical manage-
ment, does not reduce risk of death, myocardial infarction, or other major
cardiovascular events compared with optimal medical therapy alone. About
one third of patients in the medical-therapy-only group will eventually
require revascularization for symptoms or development of acute coronary
syndrome. It appears, however, that PCI can be safely deferred until symp-
toms increase or acute coronary syndrome develops.
Successful iliac vein and inferior vena cava stenting ameliorates venous
claudication and improves venous outflow, calf muscle pump function,
and clinical status in postthrombotic syndrome
Delis KT, Bjarnason H, Wennberg PW, et al. Ann Surg 2007;245:130-9.
Conclusion: Successful stenting of iliac-femoral (I-F) veins or the
inferior vena cava (IVC), or both, improves venous claudication and some
measures of venous function.
Summary: The purpose of the study was to determine effects of
successful stenting of patients with chronic venous disease. Consecutive
patients were analyzed. The patients had previously failed conservative
treatment with compression or wound care for at least 12 months. Patients
had moderate-to-advanced venous disease (CEAP classifications 3 to 6),
with or without venous claudication. Venous claudication was determined
by the judgement of at least three independent examiners. Plethysmography
was used to determine venous filling index (VFI) as a measure of venous
reflux, ejection fraction (EF) as a measure of calf muscle pump function, and
residual volume fraction (RVF) as a measure of ambulatory venous hyper-
tension. Outflow fractions at 1 and 4 seconds were also determined.
The study assessed 23 limbs in 16 patients. Control limbs (n 9) were
those limbs without infrainguinal clots on duplex scanning and without
prior I-F thrombosis. Patients were excluded if they had malignancy, stent
occlusion or stenosis, peripheral arterial disease, symptomatic cardiac dis-
ease, or unrelated causes of walking impairment.
Venous outflow and calf muscle function was reduced and RVF was
increased in the limbs with I-F  IVC thrombosis compared with the
control group (P .05 for all comparisons). At 8.4months, successful I-F
IVC stenting improved venous outflow, calf muscle pump function, and
RVF (P  .001 for all comparisons). CEAP class also improved after
intervention (P .05). Patients with successful I-F IVC stenting did have
worsening of VFI by 24% (P  .002). At 8.4 months, venous outflow, calf
muscle pump function, and RVF in the control limbs did not differ from the
stented limbs. Venous reflux as measured by VFI was worse in the stented
limbs (P .0025). Before treatment, 15 of 23 limbs (10 of 16 patients) had
incapacitating venous claudication. After successful stenting, venous claudi-
cation was eliminated in all the affected limbs (P  .001).
Comment: The study suggests that patients with venous claudication
due to an I-F venous obstruction may be improved by stenting. This study,
however, has several weaknesses: it is essentially a retrospective analysis, the
follow-up is short, there was no objective measurement of venous claudica-
tion, and only successfully treated patients were analyzed, making it impos-
sible to determine the true efficacy of I-F  IVC stenting in patients with
chronic venous disease.
Treatment of periodontitis and endothelial function
Tonetti MS, D’Aiuto F, Nibali L, et al. N Engl J Med 2007;356:911-20.
Conclusion: Acute short-term systemic inflammation and endothelial
dysfunction results from intensive periodontal treatment. Six months after
this treatment, there is improvement in endothelial function.
Summary: Atherosclerosis is an inflammatory disease. Some believe
periodontitis can be a source of chronic systemic inflammation underlying
atherosclerosis. Periodontitis is associated with elevated C-reactive protein
JOURNAL OF VASCULAR SURGERY
June 20071286 Abstracts
